AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Up 23.1% in February

AstraZeneca PLC (OTCMKTS:AZNCF) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 322,700 shares, an increase of 23.1% from the January 31st total of 262,200 shares. Based on an average daily volume of 3,200 shares, the short-interest ratio is currently 100.8 days.

AstraZeneca Trading Up 2.9 %

AZNCF stock opened at $157.58 on Thursday. The stock has a 50-day moving average price of $140.36 and a two-hundred day moving average price of $145.01. AstraZeneca has a 1 year low of $120.64 and a 1 year high of $175.00.

AstraZeneca Increases Dividend

The company also recently announced a dividend, which will be paid on Monday, March 24th. Shareholders of record on Friday, February 21st will be issued a dividend of $2.10 per share. The ex-dividend date is Wednesday, February 19th. This is a boost from AstraZeneca’s previous dividend of $1.00. AstraZeneca’s dividend payout ratio is 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.